Deferred Tax Assets, Valuation Allowance of PTC THERAPEUTICS, INC. from 31 Dec 2012 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
PTC THERAPEUTICS, INC. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2012 to 31 Dec 2025.
  • PTC THERAPEUTICS, INC. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2025 was $816,534,000, a 4.8% decline year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

PTC THERAPEUTICS, INC. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $816,534,000 -$41,050,000 -4.8% 31 Dec 2025 10-K 19 Feb 2026 2025 FY
Q4 2024 $857,584,000 +$23,774,000 +2.9% 31 Dec 2024 10-K 19 Feb 2026 2025 FY
Q4 2023 $833,810,000 +$161,638,000 +24% 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q4 2022 $672,172,000 +$146,602,000 +28% 31 Dec 2022 10-K 29 Feb 2024 2023 FY
Q4 2021 $525,570,000 +$145,962,000 +38% 31 Dec 2021 10-K 21 Feb 2023 2022 FY
Q4 2020 $379,608,000 +$112,477,000 +42% 31 Dec 2020 10-K 22 Feb 2022 2021 FY
Q4 2019 $267,131,000 +$86,650,000 +48% 31 Dec 2019 10-K 25 Feb 2021 2020 FY
Q4 2018 $180,481,000 +$2,850,000 +1.6% 31 Dec 2018 10-K 02 Mar 2020 2019 FY
Q4 2017 $177,631,000 -$5,384,000 -2.9% 31 Dec 2017 10-K 01 Mar 2019 2018 FY
Q4 2016 $183,015,000 +$43,431,000 +31% 31 Dec 2016 10-K 06 Mar 2018 2017 FY
Q4 2015 $139,584,000 +$16,301,000 +13% 31 Dec 2015 10-K 16 Mar 2017 2016 FY
Q4 2014 $123,283,000 +$255,748,000 31 Dec 2014 10-K 29 Feb 2016 2015 FY
Q4 2013 $132,465,000 -$239,335,380 -224% 31 Dec 2013 10-K 02 Mar 2015 2014 FY
Q4 2012 $106,870,380 31 Dec 2012 10-K 06 Mar 2014 2013 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.